Enhabit, Inc. (NYSE:EHAB) Expected to Earn Q3 2024 Earnings of $0.04 Per Share

Enhabit, Inc. (NYSE:EHAB - Free Report) - Analysts at Leerink Partnrs boosted their Q3 2024 EPS estimates for shares of Enhabit in a research note issued to investors on Tuesday, May 14th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $0.04 per share for the quarter, up from their prior forecast of $0.03. Leerink Partnrs has a "Hold" rating on the stock. The consensus estimate for Enhabit's current full-year earnings is $0.24 per share. Leerink Partnrs also issued estimates for Enhabit's FY2024 earnings at $0.20 EPS, Q1 2025 earnings at $0.04 EPS, Q2 2025 earnings at $0.00 EPS and Q3 2025 earnings at $0.03 EPS.

Enhabit (NYSE:EHAB - Get Free Report) last announced its earnings results on Wednesday, March 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.01. Enhabit had a positive return on equity of 1.43% and a negative net margin of 7.95%. The firm had revenue of $260.60 million during the quarter, compared to the consensus estimate of $260.30 million. During the same quarter in the prior year, the company earned $0.32 EPS.

A number of other equities research analysts also recently weighed in on EHAB. Jefferies Financial Group downgraded Enhabit from a "buy" rating to a "hold" rating and decreased their target price for the stock from $14.00 to $8.75 in a research report on Thursday, May 9th. SVB Leerink upgraded Enhabit from an "underperform" rating to a "market perform" rating and set a $8.50 price objective on the stock in a research report on Tuesday. Oppenheimer reaffirmed a "market perform" rating on shares of Enhabit in a research report on Thursday, March 7th. Finally, UBS Group raised shares of Enhabit from a "sell" rating to a "neutral" rating and set a $9.50 price target on the stock in a report on Thursday, March 7th. One investment analyst has rated the stock with a sell rating and seven have given a hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $10.13.

Enhabit Stock Performance

NYSE EHAB traded down $0.39 during midday trading on Wednesday, hitting $8.65. The company had a trading volume of 654,897 shares, compared to its average volume of 596,102. The firm has a fifty day simple moving average of $10.41 and a two-hundred day simple moving average of $10.06. The stock has a market cap of $433.55 million, a price-to-earnings ratio of -5.21, a P/E/G ratio of 1.41 and a beta of 1.98. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.75. Enhabit has a fifty-two week low of $7.12 and a fifty-two week high of $14.59.

Institutional Trading of Enhabit

Several hedge funds have recently modified their holdings of EHAB. DekaBank Deutsche Girozentrale boosted its position in Enhabit by 12,146.2% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 244,924 shares of the company's stock valued at $2,543,000 after buying an additional 242,924 shares during the last quarter. Ancora Advisors LLC raised its holdings in Enhabit by 414.5% during the 3rd quarter. Ancora Advisors LLC now owns 1,705,788 shares of the company's stock worth $19,190,000 after purchasing an additional 1,374,231 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Enhabit by 26.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 772,840 shares of the company's stock valued at $8,694,000 after purchasing an additional 160,776 shares during the last quarter. JANA Partners Management LP bought a new position in shares of Enhabit in the 3rd quarter valued at about $20,532,000. Finally, CenterBook Partners LP raised its stake in shares of Enhabit by 88.7% during the third quarter. CenterBook Partners LP now owns 301,418 shares of the company's stock worth $3,391,000 after buying an additional 141,718 shares during the last quarter.

Insiders Place Their Bets

In other Enhabit news, Director Jeffrey Bolton acquired 10,000 shares of the business's stock in a transaction on Friday, May 10th. The stock was purchased at an average price of $8.24 per share, for a total transaction of $82,400.00. Following the transaction, the director now owns 42,299 shares in the company, valued at approximately $348,543.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.90% of the company's stock.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.